SLE patients with mucocutaneous manifestations had significantly elevated MAp44 (p < 0.001) levels, while those with constitutional manifestations had significantly reduced MAp44 (p = 0.047) levels. This evidence concerns the gene MASP1 and systemic lupus erythematosus.